The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Venous Thromboembolism: Advances in Diagnosis and Treatment
Open accessAbstract
IMPORTANCE: Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal disease. OBJECTIVE: To summarize the advances in diagnosis and treatment of VTE of the past 5 years. EVIDENCE REVIEW: A systematic search was conducted in EMBASE Classic, EMBASE, Ovid MEDLINE, and other nonindexed citations using broad terms for diagnosis and treatment of VTE to find systematic reviews and meta-analyses, randomized trials, and prospective cohort studies published between January 1, 2013, and July 31, 2018. The 10th edition of the American College of Chest Physicians Antithrombotic Therapy Guidelines was screened to identify additional studies. Screening of titles, abstracts, and, subsequently, full-text articles was performed in duplicate, as well as data extraction and risk-of-bias assessment of the included articles. FINDINGS: Thirty-two articles were included in this review. The application of an age-adjusted D-dimer threshold in patients with suspected PE has increased the number of patients in whom imaging can be withheld. The Pulmonary Embolism Rule-Out Criteria safely exclude PE when the pretest probability is low. The introduction of direct oral anticoagulants has allowed for a simplified treatment of VTE with a lower risk of bleeding regardless of etiology or extent of the VTE (except for massive PE) and has made extended secondary prevention more acceptable. Thrombolysis is best reserved for patients with massive PE or those with DVT and threatened limb loss. Insertion of inferior vena cava filters should be avoided unless anticoagulation is absolutely contraindicated in patients with recent acute VTE. Graduated compression stockings are no longer recommended to treat DVT but may be used when acute or chronic symptoms are present. Anticoagulation may no longer be indicated for patients with isolated distal DVT at low risk of recurrence. CONCLUSIONS AND RELEVANCE: Over the past 5 years, substantial progress has been made in VTE management, allowing for diagnostic and therapeutic strategies tailored to individual patient characteristics, preferences, and values.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationDevelopment of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
SCHULMAN, S., ANGERÅS, U., BERGQVIST, D., ERIKSSON, B., LASSEN, M. R., & FISHER, W. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03678.x · Cited by 3,756
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
The Hokusai-VTE Investigators (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306638 · Cited by 1,869
Anderson, F. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050081016 · Cited by 1,669
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Raskob, G. E., van Es, N., Verhamme, P., Carrier, M., Di Nisio, M., Garcia, D., Grosso, M. A., Kakkar, A. K., Kovacs, M. J., Mercuri, M. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711948 · Cited by 1,633
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Apixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207541 · Cited by 1,366
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M., Humbert, M., Kucher, N., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0211 · Cited by 1,349
Young, A. M., Marshall, A., Thirlwall, J., Chapman, O., Lokare, A., Hill, C., Hale, D., Dunn, J. A., Lyman, G. H., Hutchinson, C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8034 · Cited by 1,348
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J. W., Glund, S., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kam, C.-W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707278 · Cited by 1,154
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., Kvamme, A. M., Friedman, J., Mismetti, P., & Goldhaber, S. Z. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1113697 · Cited by 983
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
Vedantham, S., Goldhaber, S. Z., Julian, J. A., Kahn, S. R., Jaff, M. R., Cohen, D. J., Magnuson, E., Razavi, M. K., Comerota, A. J., Gornik, H. L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615066 · Cited by 866
van Es, N., Coppens, M., Schulman, S., Middeldorp, S., & Büller, H. R. (2014) · Blood · doi:10.1182/blood-2014-04-571232 · Cited by 851
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Connolly, S. J., Milling, T. J., Eikelboom, J. W., Gibson, C. M., Curnutte, J. T., Gold, A., Bronson, M. D., Lu, G., Conley, P. B., Verhamme, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607887 · Cited by 807
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700518 · Cited by 787
Self-citationKearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationBates, S. M., Jaeschke, R., Stevens, S. M., Goodacre, S., Wells, P. S., Stevenson, M. D., Kearon, C., Schunemann, H. J., Crowther, M., Pauker, S. G., et al. (2012) · Chest · doi:10.1378/chest.11-2299 · Cited by 686
Self-citationAujesky, D., Roy, P.-M., Verschuren, F., Righini, M., Osterwalder, J., Egloff, M., Renaud, B., Verhamme, P., Stone, R. A., Legall, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60824-6 · Cited by 598
Kearon, C., Ageno, W., Cannegieter, S. C., Cosmi, B., Geersing, G. ‐., & Kyrle, P. A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13336 · Cited by 587
Rodger, M. A., Kahn, S. R., Wells, P. S., Anderson, D. A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080493 · Cited by 581
Self-citationvan der Hulle, T., Cheung, W. Y., Kooij, S., Beenen, L. F. M., van Bemmel, T., van Es, J., Faber, L. M., Hazelaar, G. M., Heringhaus, C., Hofstee, H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30885-1 · Cited by 548
Kline, J. A., Mitchell, A. M., Kabrhel, C., Richman, P. B., & Courtney, D. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00790.x · Cited by 511
Eichinger, S., Heinze, G., Jandeck, L. M., & Kyrle, P. A. (2010) · Circulation · doi:10.1161/circulationaha.109.925214 · Cited by 510
Mismetti, P., Laporte, S., Pellerin, O., Ennezat, P.-V., Couturaud, F., Elias, A., Falvo, N., Meneveau, N., Quere, I., Roy, P.-M., et al. (2015) · JAMA · doi:10.1001/jama.2015.3780 · Cited by 489
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.024 · Cited by 463
TOSETTO, A., IORIO, A., MARCUCCI, M., BAGLIN, T., CUSHMAN, M., EICHINGER, S., PALARETI, G., POLI, D., TAIT, R. C., & DOUKETIS, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04735.x · Cited by 443
Khorana, A. A., Noble, S., Lee, A. Y. Y., Soff, G., Meyer, G., O'Connell, C., & Carrier, M. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14219 · Cited by 442
Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study
ZONDAG, W., MOS, I. C. M., CREEMERS‐SCHILD, D., HOOGERBRUGGE, A. D. M., DEKKERS, O. M., DOLSMA, J., EIJSVOGEL, M., FABER, L. M., HOFSTEE, H. M. A., HOVENS, M. M. C., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04388.x · Cited by 382
CARRIER, M., RIGHINI, M., WELLS, P. S., PERRIER, A., ANDERSON, D. R., RODGER, M. A., PLEASANCE, S., & LE GAL, G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03938.x · Cited by 381
Self-citationThrombolysis for acute deep vein thrombosis
Watson, L., Broderick, C., & Armon, M. P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002783.pub4 · Cited by 372
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
Konstantinides, S. V., Vicaut, E., Danays, T., Becattini, C., Bertoletti, L., Beyer-Westendorf, J., Bouvaist, H., Couturaud, F., Dellas, C., Duerschmied, D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.12.039 · Cited by 361
Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009)
Huang, W., Goldberg, R. J., Anderson, F. A., Kiefe, C. I., & Spencer, F. A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.041 · Cited by 297
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
Verbelen, M., Weale, M. E., & Lewis, C. M. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.21 · Cited by 240
Rodger, M. A., Le Gal, G., Anderson, D. R., Schmidt, J., Pernod, G., Kahn, S. R., Righini, M., Mismetti, P., Kearon, C., Meyer, G., et al. (2017) · BMJ · doi:10.1136/bmj.j1065 · Cited by 238
Geersing, G. J., Zuithoff, N. P. A., Kearon, C., Anderson, D. R., ten Cate-Hoek, A. J., Elf, J. L., Bates, S. M., Hoes, A. W., Kraaijenhagen, R. A., Oudega, R., et al. (2014) · BMJ · doi:10.1136/bmj.g1340 · Cited by 227
Self-citationPomero, F., Borretta, V., Bonzini, M., Melchio, R., Douketis, J. D., Fenoglio, L. M., & Dentali, F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0473 · Cited by 197
Analysis of National Trends in Admissions for Pulmonary Embolism
Smith, S. B., Geske, J. B., Kathuria, P., Cuttica, M., Schimmel, D. R., Courtney, D. M., Waterer, G. W., & Wunderink, R. G. (2016) · Chest · doi:10.1016/j.chest.2016.02.638 · Cited by 191
Palareti, G., Cosmi, B., Legnani, C., Antonucci, E., De Micheli, V., Ghirarduzzi, A., Poli, D., Testa, S., Tosetto, A., Pengo, V., et al. (2014) · Blood · doi:10.1182/blood-2014-01-548065 · Cited by 190
Thrombolytic therapy for pulmonary embolism
Dong, B. R., Hao, Q., Yue, J., Wu, T., & Liu, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004437.pub3 · Cited by 174
Righini, M., Galanaud, J.-P., Guenneguez, H., Brisot, D., Diard, A., Faisse, P., Barrellier, M.-T., Hamel-Desnos, C., Jurus, C., Pichot, O., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30131-4 · Cited by 170
Self-citationBorrego, M. E., Woersching, A. L., Federici, R., Downey, R., Tiongson, J., Bieniarz, M. C., Cavanaugh, B. J., Spyropoulos, A. C., & Mahan, C. E. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0162 · Cited by 167
van Es, N., van der Hulle, T., van Es, J., den Exter, P. L., Douma, R. A., Goekoop, R. J., Mos, I. C. M., Galipienzo, J., Kamphuisen, P. W., Huisman, M. V., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0031 · Cited by 163
Freund, Y., Cachanado, M., Aubry, A., Orsini, C., Raynal, P.-A., Féral‐Pierssens, A., Charpentier, S., Dumas, F., Baarir, N., Truchot, J., et al. (2018) · JAMA · doi:10.1001/jama.2017.21904 · Cited by 155
Kearon, C., Spencer, F. A., O’Keeffe, D., Parpia, S., Schulman, S., Baglin, T. P., Stevens, S. M., Kaatz, S., Bauer, K. A., Douketis, J. D., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1275 · Cited by 154
Gómez‐Outes, A., Terleira‐Fernández, A. I., Lecumberri, R., Suárez‐Gea, M. L., & Vargas, E. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.06.020 · Cited by 148
Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis
Piran, S., Gal, G. L., Wells, P. S., Gándara, E., Righini, M., Rodger, M. A., & Carrier, M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.012 · Cited by 144
Self-citationEngelberger, R. P., Spirk, D., Willenberg, T., Alatri, A., Do, D.-D., Baumgärtner, I., & Kucher, N. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002027 · Cited by 131
Penaloza, A., Soulié, C., Moumneh, T., Delmez, Q., Ghuysen, A., Kouri, D. E., Brice, C., Marjanovic, N. S., Bouget, J., Moustafa, F., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30210-7 · Cited by 101
Phillips, J. J., Straiton, J., & Staff, R. T. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.03.013 · Cited by 96
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis
Franco, L., Giustozzi, M., Agnelli, G., & Becattini, C. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13677 · Cited by 91
Raskob, G. E., Ageno, W., Cohen, A. T., Brekelmans, M. P. A., GROSSO, M. A., Segers, A. E. M., Meyer, G., Verhamme, P. B., Wells, P. S., Lin, M., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)00023-5 · Cited by 68
Self-citationRodrigues, J. D. C., Alzuphar, S., Combescure, C., Gal, G. L., & Perrier, A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13407 · Cited by 66
Turner, T. E., Saeed, M. J., Novak, E. L., & Brown, D. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0452 · Cited by 65
Trends in case fatality rate in pulmonary embolism according to stability and treatment
Stein, P. D., Matta, F., Alrifai, A. Z. A., & Rahman, A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.07.011 · Cited by 62
Engelberger, R. P., Stuck, A. K., Spirk, D., Willenberg, T., Haine, A., Périard, D., Baumgärtner, I., & Kucher, N. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13709 · Cited by 62
Gómez-Outes, A., Lecumberri, R., Suárez-Gea, M. L., Terleira-Fernández, A.-I., Monreal, M., & Vargas-Castrillón, E. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415575154 · Cited by 57
Subbiah, R., Aggarwal, V., Zhao, H., Kolluri, R., Chatterjee, S., & Bashir, R. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30017-5 · Cited by 57
Marik, P. E., & Cavallazzi, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143252 · Cited by 53
Reddy, S., Lakhter, V., Zack, C. J., Zhao, H., Chatterjee, S., & Bashir, R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.2719 · Cited by 50
Lozano, F. S., Trujillo‐Santos, J., Barrón, M., Gallego, P., Babalis, D., Santos, M., Falgà-Tirado, C., & Monréal, M. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.11.091 · Cited by 44
Abdalla, G. M., Matuk, R. F., Venugopal, V., Verde, F., Magnuson, T. H., Schweitzer, M., & Steele, K. E. (2015) · Clinical Radiology · doi:10.1016/j.crad.2015.04.007 · Cited by 42
Thrombolytic therapy for pulmonary embolism
Hao, Q., Dong, B. R., Yue, J., Wu, T., & Liu, G. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004437.pub4 · Cited by 42
Riva, N., Puljak, L., Moja, L., Ageno, W., Schünemann, H. J., Magrini, N., & Squizzato, A. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.11.012 · Cited by 39
Emergency Visits for Oral Anticoagulant Bleeding
Geller, A. I., Shehab, N., Lovegrove, M. C., Rose, K. O., Weidle, N. J., Goring, S. K., & Budnitz, D. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05391-y · Cited by 37
Warfarin initiation nomograms for venous thromboembolism
Lázaro, P. P. G., Ruiz, W., & Munarriz, C. A. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007699.pub3 · Cited by 29
Precision dosing to avoid adverse drug reactions
Polasek, T. M., Kirkpatrick, C. M. J., & Rostami‐Hodjegan, A. (2019) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098619894147 · Cited by 29
Panova‐Noeva, M., van der Meijden, P. E. J., & Cate, H. T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010092 · Cited by 23
Squizzato, A., Pomero, F., Allione, A., Priotto, R., Riva, N., Huisman, M. V., Klok, F. A., Stein, P. D., Guasti, L., Fenoglio, L. M., et al. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.03.027 · Cited by 16
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Khan, F., Tritschler, T., Kahn, S. R., & Rodger, M. A. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32658-1 · Cited by 753
Self-citationA Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
Metadata
- Authors
- Tritschler, T., Kraaijpoel, N., Le Gal, G., & Wells, P. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-10-16
- Volume
- 320
- Issue
- 15
- Pages
- 1583
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2897158139
- Cited by
- 357
- References
- 72
- FWCI
- 27.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.